Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

AstraZeneca to pause £200m Cambridge investment, shares slump

Mon 15 Sep 2025 08:58

(Sharecast News) - AstraZeneca slumped on Monday after saying it was pausing plans to invest £200m at its Cambridge research site. The pharmaceuticals giant confirmed the move after the close on Friday.

A spokesperson for the company said: "We constantly reassess the investment needs of our company and can confirm our expansion in Cambridge is paused. We have no further comment to make."

The confirmation came after Reuters said the decision on the investment, which had been set to create 1,000 jobs, means that none of AstraZeneca's planned new funding - originally announced in March 2024 - is currently proceeding.

In January, AstraZeneca scrapped plans to invest £450m in its vaccine manufacturing plant in northern England, citing a cut in government support.

At 0935 BST, the shares were down 3.4% at 11,390p.

Richard Hunter, head of markets at Interactive Investor, said this was "hot on the heels of other pharmaceutical strategic withdrawals given the perceived lack of interest from the government".

He added: "Despite the dip, the shares are up by 21% so far this year, but from a UK perspective such moves add to the possibility that Astra could seek to reflect its US exposure by switching its primary listing, which would be a major reputational blow."

Share this article

Related Sharecast Articles

Wed 12 Aug 2026 09:14
JPMorgan reiterates 'overweight' on Ocado, lifts price target
(Sharecast News) - JPMorgan reiterated its 'overweight' rating on Ocado on Wednesday and lifted the price target to 290p from 245p as it continues to view the risk/reward as "highly attractive".
Wed 12 Aug 2026 08:15
CLS posts sharply wider statutory loss as EPRA earnings decline
(Sharecast News) - Property investment firm CLS Holdings reported a significantly wider interim statutory loss and a steep drop in EPRA earnings on Wednesday, reflecting lower rental income, valuation declines and continued portfolio repositioning.
Wed 12 Aug 2026 07:55
Evoke profits fall, revenue flat as 888 owner hit by gaming duties
(Sharecast News) - William Hill and 888 owner Evoke reported a drop in interim profit on Wednesday and flat revenue, as it took a hit from gaming duties.
Wed 12 Aug 2026 07:27
Berenberg starts Raspberry Pi at 'hold', citing mixed risk‑reward
(Sharecast News) - Analysts at Berenberg initiated coverage of Raspberry Pi with a 'hold' recommendation and 670p target price on Wednesday, saying the group's long‑term growth potential was clear but balanced by structural risks, forecasting challenges and near‑term margin uncertainty.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026